Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1666.9000 -11.00 (-0.66%)
NSE Oct 16, 2026 15:31 PM
Volume: 796.7K
 

1666.90
-0.66%
Motilal Oswal
Under the Production-Linked Incentive (PLI) scheme, ARBP constructed the PENG and 6-APA plants within a record three-year period and ramped up production following the start of the PEN-G plant in Jul’25.
Aurobindo Pharma Ltd. is trading below its 30 day SMA of 1683.7
More from Aurobindo Pharma Ltd.
Recommended